- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Pfizer Inc (PFE)
| Open: | 28.7100 | Day's Range: | 28.3100 - 28.8300 | Volume: | 44,108,264 |
|---|---|---|---|---|---|
| Previous Close: | 28.7000 | 52wk Range: | 21.4000 - 31.1500 | 1-Yr Rtn: | +33.27% |
Key Statistics for PFE
| Current P/E Ratio (ttm) | 13.3241 |
|---|---|
| Estimated P/E(12/2013) | 12.9465 |
| Relative P/E vs. SPX | 0.8173 |
| Earnings Per Share (USD) (ttm) | 2.1600 |
| Est. EPS (USD) (12/2013) | 2.2230 |
| Est. PEG Ratio | 2.8560 |
| Market Cap (M USD) | 204,142.97 |
| Shares Outstanding (M) | 7,093.22 |
| 30 Day Average Volume | 36,614,724 |
| Price/Book (mrq) | 2.4831 |
| Price/Sale (ttm) | 3.6753 |
| Dividend Indicated Gross Yield | 3.34% |
| Cash Dividend (USD) | 0.2400 |
| Last Dividend | 05/08/2013 |
| 5 Year Dividend Growth | -5.49% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PFE
Company Profile & Key Executives for PFE
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
| Ian C ReadChairman/CEO | Olivier BrandicourtPres & Gen Mgr:Emerging Market |
| John D YoungPres & Gen Mgr:Primary Care | Geno J GermanoPres & Gen Mgr:Specialty Care |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PFE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page